WFSBP Programme 2015

64 / 112

62
WFSBP 2015
Scientific Programme | Wednesday, 17 June 2015
T40: Schizophrenia: Basic / Clinical
TG-06 WFSBP Treatment Guidelines
15:00–16:30 Skalkotas Hall
Task Force on Schizophrenia
Chair: Peter Falkai, Germany
Co-Chair: Alkomiet Hasan, Germany
TG-06-001
WFSBP Guidelines on the acute treatment of schizophrenia
Alkomiet Hasan, Germany
TG-06-002
WFSBP Guidelines on the long-term treatment of schizo­
phrenia
Thomas Wobrock, Germany
TG-06-003
Treatment guideline for the early phase of schizophrenia/
psychosis
Eric Chen, People‘s Republic of China
T1: Addictive Disorders
D-02 Debate
11:00–12:30 Trianti Hall
Behavioral addictions–normality or deviance?
Chair: Florence Thibaut, France
Co-Chair: Victoria Valdez de Vuibert, Ecuador
Proponent: Marc Potenza, USA
Opponent: Pier Vincenzo Piazza, France
T9: Dementia : Basic/ Clinical
WS-16 Workshop
16:30–18:00 Mitropoulos Hall
Development of biological markers for differential
diagnosis of dementia in physiological and biochemical
strategies
Chair: Toshihisa Tanaka, Japan
Co-Chair: Fernando Maestu, Spain
WS-16-001
Magnetoencephalography for diagnose and evaluation of
dementia
Fernando Maestu, Spain
WS-16-002
Functional connectivity in EEG for diagnosis of Alzheimer
disease
Leonides Canuet, Spain
WS-16-003
Screening of cognitive impairment and diagnosis of dementia
Katsuya Urakami, Japan
WS-16-004
CSF biomarkers in differential diagnosis of dementia
Toshihisa Tanaka, Japan
M. Terada, M. Sato, M. Takeda
T40: Schizophrenia: Basic/ Clinical
WS-11 Workshop
16:30–18:00 Skalkotas Hall
Treatment of schizophrenia: Personalized tailoring to
meet patients needs
Chair: Konstantinos Fountoulakis, Greece
Co-Chair: Cyril Hoschl, Czech Republic
WS-11-001
Antipsychotics: Differences and specificity
Alessandro Serretti, Italy
WS-11-002
Information technology aided relapse prevention in schizo­
phrenia (itareps)
Cyril Hoschl, Czech Republic
F. Spaniel
WS-11-003
Computer-assisted treatment pathway for schizophrenia:
Development and first results in over 200 patients
Georg Juckel, Germany
WS-11-004
The optimization effect in schizophrenia: Why we see dif-
ferent things in everyday clinical practice
Konstantinos Fountoulakis, Greece
T10: Depression: Basic/ Clinical
WS-12 Workshop
16:30–18:00 MC 3 Room
Task force recommendations for the management of
comorbidity in major depressive disorder and bipolar
disorder
Chair: Roumen Milev, Canada
Co-Chair: Serge Beaulieu, Canada
WS-12-001
The comorbidity of mental and bone health: A fracture
line ready to break?
Michael Berk, Canada
WS-12-002
Management of patients with comorbid mood and anxiety
disorders
Roumen Milev, Canada
A. Schaffer